2026 Annual Young Women’s Health Day on the Hill – HEAL Policy Center of Excellence

12th Annual Young Women’s Health Day on the Hill (YWHD)

#CuresCantWait

Join us for Tigerlily‘s 12th Annual Young Women’s Health Day on the Hill (YWHD)– a policy briefing luncheon where patient voices meet action on Capitol Hill. With two panel discussions, we will discuss the Clinical Trial Modernization Act, the Safe Step Act and how YOU can make an impact in ensuring patients have access to new and existing treatments now.

Wednesday, June 3rd, 2026

1:00—2:30 PM ET 

Rayburn House Office Building
45 Independence Ave SW, Room 2044
Washington, DC

Hear from patient experts, patient advocacy groups and medical experts about the importance of financial support for patients to participate in clinical trials, the patient harms of step therapy and how we can all ensure there are protections for patients to access their life-saving treatments.

Moderator:

Maimah Karmo

Founder & CEO, Tigerlily Foundation

Panelists:

Camille Lewis

Tigerlily ANGEL Advocate, Breast Health Justice Advocate & Breast Cancer Survivor

Nishith Pandya

Director, Federal Advocacy American Cancer Society, Cancer Action Network

Paris Smith

Tigerlily ANGEL Advocate & Breast Cancer Survivor

Special Remarks:

Rep. Lucy McBath

(GA-06)

Panel 1

Clinical Trial Modernization Act &
Financial Barriers to Clinical Trials

Panel 2

Step Therapy & Patient Impacts:
The Safe Step Act & Regulatory Fixes

Lunch will be provided

This is a unique opportunity to hear directly from patient advocates, policy experts, and a member of Congress about two critical issues: making clinical trials more accessible and ending harmful step therapy practices. Your presence and voice can help drive change – because #Access #CantWait.

2721503_HEALCOEQuoteGraphics_2_Camille_1080x1920_040826 (1)

4iyrRFEX8v-2721503_HEALCOEQuoteGraphics_Paris_1080x1920_050426

The EPIC Act

The Ensuring Pathways to Innovative Cures (EPIC) Act would help protect access to and innovation of small molecule cancer drugs— pill form—like oral chemotherapy. This change would encourage companies to invest in additional clinical trials for cancer treatments that could make a real difference for patients.

» Learn more HERE.

The ORPHAN Cures Act

The Optimizing Research Progress Hope And New (ORPHAN) Cures Act would help protect research for rare diseases while ensuring affordability. Orphan drugs are drugs used to treat rare diseases which are defined as diseases affecting fewer than 200,000 people.

» Learn more HERE.